US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

COLL Collegium Pharmaceutical Inc

28.14

-0.88 (-3.03%)

04 Abr 2025 - Cerrado

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Thomas B Smith

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Collegium Pharmaceutical (NASDAQ:COLL)
Gráfica de Acción Histórica
De Mar 2025 a Abr 2025

Haga Click aquí para más Gráficas Collegium Pharmaceutical.

Collegium Pharmaceutical (NASDAQ:COLL)
Gráfica de Acción Histórica
De Abr 2024 a Abr 2025

Haga Click aquí para más Gráficas Collegium Pharmaceutical.

Noticias sobre Collegium Pharmaceutical Inc COLL

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference
Martes 1 de Abril 2025 (5 días hace) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Viernes 28 de Marzo 2025 (1 semana hace) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Viernes 28 de Marzo 2025 (1 semana hace) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Viernes 28 de Marzo 2025 (1 semana hace) • Edgar (US Regulatory)

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
Jueves 27 de Marzo 2025 (1 semana hace) • GlobeNewswire Inc.

Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
Miércoles 26 de Marzo 2025 (2 semanas hace) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 24 de Marzo 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lunes 24 de Marzo 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Viernes 21 de Marzo 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Viernes 21 de Marzo 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jueves 20 de Marzo 2025 (2 semanas hace) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Jueves 20 de Marzo 2025 (2 semanas hace) • Edgar (US Regulatory)

Más de Collegium Pharmaceutical Inc Artículos de Noticias

Euro vs US Dollar

JP Morgan Chase

US Dollar vs MXN

Invesco QQQ Trust Series 1

Bank of America

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones